Nancy Wysenski

Nancy Wysenski served as the Executive Vice President and Chief Commercial Officer of Vertex Pharmaceuticals from 2009 through her retirement in 2012. During her tenure at Vertex, Nancy was responsible for the launches of Incivek and Kalydeco. Prior to joining Vertex, Nancy was Chief Operating Officer of Endo Pharmaceuticals, a specialty pharmaceutical company, where she led sales, marketing, commercial operations, supply-chain management, human resources, and various business development initiatives. Prior to her role at Endo, Nancy participated in the establishment of EMD Pharmaceuticals, Inc., where she served as President and Chief Executive Officer from 2001 to 2006 and Vice President of Commercial from 1999 to 2001. From 1984 to 1998, Nancy held several sales-focused roles at major pharmaceutical companies, including Vice President of Field Sales for Astra Merck, Inc.

Nancy serves as a member of the board of directors of Alkermes plc and Tetraphase Pharmaceuticals, each a publicly traded pharmaceutical company. She formerly served as a director for Dova Pharmaceuticals Inc., Reata Pharmaceuticals, Inc. and Inovio Pharmaceuticals, Inc. In addition, she is a founder of the Research Triangle Park chapter of the Healthcare Business Women's Association and served on the Nominating Committee and National Advisory Board of the Healthcare Businesswomen's Association.